AI-powered voice screening for COVID earns CE mark

Dave Pearson | | Health Exec | Economics
Voice Recognition Smartphone

Photo by Ekaterina Bolovtsova via Pexels

An Israeli AI startup has been cleared to market COVID-detecting voice analysis software in Europe, according to No Camels.

Vocalis Health announced the CE mark win Feb. 17, saying its VocalisCheck product can be accessed by smartphones and is intended to serve as an initial screening tool, not a definitive diagnostic tester.

The company says the system achieved good accuracy, 81%, in a recent clinical trial involving more than 2,000 people in India. The participants represented speakers of at least four languages.

Vocalis is working with Mayo Clinic on refining the software and expanding its applications for voice-based health screening.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Zimmer agrees to buy Paragon 28 for $1.1B
Cardiologist-founded startup raises $2M in the name of women’s heart health
Following announced funding freeze, White House confirms Medicaid portals are down
Philips to sell its emergency care business to private equity firm
Cardiologist sues health system over gender discrimination, unequal pay and hostile treatment
FTC, DOJ and HHS release report warning of private equity consolidation in healthcare

Around the web

Radiology Business
ACR shares guidance to help members deal with confusing White House executive orders

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Cardiovascular Business
Philips to sell its emergency care business to private equity firm

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

AI in Healthcare
Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.